Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis.

Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis.

Item
http://www.wikidata.org/entity/Q42241908
Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on preventionEstimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria.Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases.Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?Human papillomavirus vaccination for men: advancing policy and practice
P2860

Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis.

Item
http://www.wikidata.org/entity/Q42241908
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Universal vaccination with the ...... d cost-effectiveness analysis.
@en
Universal vaccination with the ...... d cost-effectiveness analysis.
@nl
type
label
Universal vaccination with the ...... d cost-effectiveness analysis.
@en
Universal vaccination with the ...... d cost-effectiveness analysis.
@nl
prefLabel
Universal vaccination with the ...... d cost-effectiveness analysis.
@en
Universal vaccination with the ...... d cost-effectiveness analysis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Universal vaccination with the ...... d cost-effectiveness analysis.
@en
P2093
P2860
P304
P31
P356
10.1586/14737167.2014.881253
P433
P478
P577
P5875
P698
P921